Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Baxter International Inc Unveils Projected Earnings and Sales Growth for 2024

Elaine Mendonca by Elaine Mendonca
February 8, 2024
in Breaking News
0
Healthcare-sector
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Baxter International Inc. has recently unveiled its projected adjusted earnings per share (EPS) for the entire year of 2024, anticipating a range between $2.85 and $2.95. This forecast slightly deviates from the consensus of $2.94. In addition, the company foresees a growth rate of approximately 2% in sales, both on a reported and constant currency basis, during the same period.

These projections have been formulated based on Baxter International Inc.’s fourth-quarter results and their outlook for the first quarter of 2024. The company’s analysis suggests a relatively stable performance with a modest upsurge in sales.

It is worth noting that this information is unique to Baxter International Inc. and pertains to their future expectations as of February 8, 2024.

BAX Stock Shows Positive Momentum with 2.73% Rise: Analysis and Outlook

On February 8, 2024, BAX stock showed positive momentum as it recorded a 2.73% rise in its price. The stock opened at $38.84, which was $0.54 lower than its previous close. These figures indicate that BAX experienced a strong start to the trading day.

One important factor to consider when analyzing BAX’s performance is its position relative to its 52-week range and its 200-day simple moving average. As of February 8, BAX was trading in the middle of its 52-week range, suggesting that it has not reached its highest or lowest point within the past year. This indicates a level of stability in the stock’s performance.

Furthermore, BAX was also trading near its 200-day simple moving average. The 200-day moving average is a commonly used technical indicator that provides insight into the long-term trend of a stock. When a stock is trading near its 200-day moving average, it suggests that the stock’s price is relatively stable and not deviating significantly from its long-term trend.

The price change on February 8, 2024, is particularly noteworthy. BAX shares increased by $1.07 since the market last closed. This represents a 2.73% rise in the stock’s price. Such a significant increase indicates positive investor sentiment and suggests that there may be underlying factors driving the stock’s performance.

Investors should keep an eye on BAX and monitor any further developments. Positive price momentum and a strong start to the trading day indicate that BAX may continue to perform well in the near future. However, it is important to conduct thorough research and analysis before making any investment decisions.

BAX Stock Performance on February 8, 2024: Revenue Growth and Declining Profits

Title: BAX Stock Performance on February 8, 2024: Revenue Growth and Declining Profits

Introduction:
On February 8, 2024, Baxter International Inc. (BAX) witnessed a mixed performance in terms of its stock performance. While the company reported a notable increase in total revenue since last year, its net income and earnings per share (EPS) suffered significant declines. This article will delve into the details of BAX’s financial performance on February 8, 2024.

Revenue Growth:
Baxter International Inc. generated a total revenue of $15.11 billion over the last year, marking an 18.22% increase compared to the previous year. However, the total revenue remained flat since the last quarter.

Net Income Decline:
In contrast to the growth in revenue, Baxter International Inc. experienced a decline in net income. Over the last year, the company reported a net income of -$2.43 billion, reflecting a significant decrease of 289.49% compared to the previous year. However, the net income increased by 124.62% since the previous quarter, reaching $48.00 million.

Earnings per Share (EPS) Decrease:
Baxter International Inc.’s earnings per share (EPS) also witnessed a decline. Over the last year, the EPS stood at -$4.83, representing a significant decrease of 290.99% compared to the previous year. Furthermore, the EPS also decreased by 170.33% since the last quarter, reaching -$0.75.

Conclusion:
The stock performance of Baxter International Inc. on February 8, 2024, showcased a mixed bag of results. While the company witnessed a commendable increase in total revenue since the previous year, its net income and earnings per share experienced significant declines. Investors should closely monitor Baxter International Inc.’s financial performance in the coming quarters to assess its ability to overcome these challenges and regain profitability.

Tags: BAX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare-sector

Baxter International Inc Projects Optimistic Performance and Growth Outlook

FLO stock news

Analyst Downgrades American Finl Gr with Neutral Rating and Lower Price Target

Renewable energy

Plug Power Enhances Hydrogen Generation Network with Cryogenic Trailers for Efficient Customer Deliveries

Recommended

Analyst Ratings Show Bullish Sentiments for Boston Scientific

2 years ago
D-Wave Quantum Stock

D-Wave Quantum Shares Surge Ahead of Earnings Report

7 days ago
Finance_Fiscal (2)

Taboolas Strong Financial Performance and Growth Outlook for 2024

2 years ago
Healthcare-and-IT

Analyst Ratings and Price Targets for Evolent Health Recent Updates and Insights

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ethereum’s Institutional Bet: Whales Accumulate Amid Market Turbulence

Hedge Funds Target Xiaomi as Short Positions Surge Ahead of Earnings

Diginex Expands RegTech Capabilities with Strategic Edge AI Acquisition

Can Strategic Shifts Reverse JetBlue’s Fortunes?

Fannie Mae Shares Face Intensifying Pressure Amid Leadership Overhaul

Technology Sector at a Crossroads: Can AI Momentum Sustain ETF Valuations?

Trending

Block Stock
Analysis

Block Investors Brace for Pivotal Earnings Report

by Dieter Jaworski
November 6, 2025
0

Today marks a critical juncture for Block shareholders as the financial technology firm prepares to release quarterly...

Nestle Stock

Nestlé Faces Dual Setbacks as Patent Denial Meets Analyst Downgrade

November 6, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Defy Strong Performance with Steep Decline

November 6, 2025
Ethereum Stock

Ethereum’s Institutional Bet: Whales Accumulate Amid Market Turbulence

November 6, 2025
Xiaomi Stock

Hedge Funds Target Xiaomi as Short Positions Surge Ahead of Earnings

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Block Investors Brace for Pivotal Earnings Report
  • Nestlé Faces Dual Setbacks as Patent Denial Meets Analyst Downgrade
  • Redcare Pharmacy Shares Defy Strong Performance with Steep Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com